Solid Biosciences (SLDB) Return on Sales (2022 - 2024)
Historic Return on Sales for Solid Biosciences (SLDB) over the last 3 years, with Q4 2024 value amounting to 507.28%.
- Solid Biosciences' Return on Sales fell 2952800.0% to 507.28% in Q4 2024 from the same period last year, while for Dec 2024 it was 354.7%, marking a year-over-year decrease of 4478600.0%. This contributed to the annual value of 354.7% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q4 2024, Solid Biosciences' Return on Sales is 507.28%, which was down 2952800.0% from 401.66% recorded in Q3 2024.
- In the past 5 years, Solid Biosciences' Return on Sales ranged from a high of 905.26% in Q3 2023 and a low of 12.73% during Q4 2022
- Over the past 3 years, Solid Biosciences' median Return on Sales value was 287.62% (recorded in 2024), while the average stood at 389.55%.
- Its Return on Sales has fluctuated over the past 5 years, first soared by 9126300bps in 2023, then crashed by -6105200bps in 2024.
- Over the past 3 years, Solid Biosciences' Return on Sales (Quarter) stood at 12.73% in 2022, then surged by 6406bps to 802.56% in 2023, then tumbled by -37bps to 507.28% in 2024.
- Its last three reported values are 507.28% in Q4 2024, 401.66% for Q3 2024, and 287.62% during Q2 2024.